Managing moderate or severe postoperative pain, which affects 75% of patients in the United States, remains a challenge for physicians.
The FDA has accepted the resubmitted NDA for XaraColl® for the management of postsurgical pain after open inguinal hernia surgery.
A systemwide, multipronged pain management and opioid reduction program can significantly reduce opioid discharge prescriptions written for more than five days.
Higher serum testosterone levels were associated with less WOMAC pain in the operated knee in both men and women, and less WOMAC disability in women.
Patients undergoing corneal surgery and receiving fewer opioid tablets still have adequate pain control.
Femoral nerve block was superior to adductor canal block in terms of intravenous morphine consumption after TKA.
Higher levels of total testosterone were found to be associated with reduced pain intensity in the operated knee of patients who underwent total knee replacement for severe knee osteoarthritis.
HTX-011 is a dual-acting, fixed-dose combination of bupivacaine and meloxicam.
A significant percentage of patients who are prescribed opioids after ureteroscopy for the treatment of upper tract stones were found to have new persistent opioid use.
Colorectal surgery patients treated as part of an enhanced recovery after surgery (ERAS) program have less pain and use nearly half as many opioids as pre-ERAS patients.